androstenedione has been researched along with Adenoma, Prostatic in 76 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 45 (59.21) | 18.7374 |
1990's | 27 (35.53) | 18.2507 |
2000's | 2 (2.63) | 29.6817 |
2010's | 1 (1.32) | 24.3611 |
2020's | 1 (1.32) | 2.80 |
Authors | Studies |
---|---|
Chen, S; Hu, Y; Huang, Y; Jiang, Z; Liu, J; Lu, Q; Wang, H; Yang, T; Yin, X; Zhou, Y | 1 |
Amoah, BY; Anang, Y; Asare, GA; Asiedu, B; Doku, DA; Ngala, RA; Nyarko, A; Santa, S | 1 |
Benghuzzi, HA; Pollan, MC; Tucci, M | 1 |
Habib, FK | 1 |
Ghanadian, R; Masters, JR; Smith, CB | 1 |
Hudson, RW | 1 |
Bolton, NJ; Kontturi, M; Lahtonen, R; Vihko, P; Vihko, R | 1 |
Corrales Hernández, JJ; García Diez, LC; Hoisaeter, PA; Martin, T; Miralles García, JM; Montero Gómez, J | 1 |
Killinger, DW; Perel, E | 1 |
Corrales Hernández, JJ; García Díez, LC; Martín Rodríguez, M; Miralles García, JM; Montero Gómez, J | 1 |
Bélanger, A; Dubé, JY; Frenette, G; Labrie, F; Tremblay, RR; Tremblay, Y | 1 |
Goldschmidt, AJ; Tunn, UW | 1 |
Andriole, GL; Keetch, DW | 1 |
el Etreby, MF; Habenicht, UF | 3 |
el Etreby, MF; Gormley, GJ; Imperato-McGinley, JL; Oesterling, JE; Roehrborn, CG; Schröder, FH; Tunn, UW | 1 |
Gann, PH; Grodstein, F; Hennekens, CH; Longcope, C; Stampfer, MJ; Verhoek-Oftedahl, W | 1 |
Eri, LM; Haug, E; Tveter, KJ | 2 |
Gingell, JC; Knönagel, H; Kurth, KH; Tunn, UW | 1 |
Ekman, P | 1 |
Geller, J | 1 |
Bartsch, G; el Etreby, MF; Habenicht, UF; Schröder, FH; Schweikert, HU; Senge, T; Tunn, UW | 1 |
Arnold, J; Blom, JH; Ennemoser, O; Habenicht, UF; Horniger, W; Schröder, FH; Schulze, H; Schweikert, HU; Senge, T; Tunn, UW | 1 |
el Etreby, MF | 1 |
Kawakami, E; Makanae, Y; Ogasa, A; Orima, H; Shimizu, M; Tsutsui, T; Yajima, K | 1 |
Honma, S; Ito, K; Suzuki, K; Suzuki, T; Tamura, Y; Yamanaka, H | 1 |
Hampl, R; Hill, M; Petrík, R; Stárka, L | 2 |
Bono, AV; Eickenberg, HU; Fletcher, MS; Fourcade, RO; Radlmaier, A; Reis Santos, JM; van Aubel, OG | 1 |
Chisholm, GD; Habib, FK; Hayashi, Y; Kohri, K; Ross, M; Tanaka, S; Tozawa, K; Tsugaya, M | 1 |
Chisholm, GD; Habib, FK; Ross, M; Tate, R | 1 |
Bílek, R; Hampl, R; Hill, M; Lapcík, O; Petrik, R; Stárka, L | 1 |
Colciago, A; Motta, M; Negri-Cesi, P; Poletti, A | 1 |
Hartmann, RW; Jose, J; Michel, A; Reichert, W | 1 |
Altwein, JE; Orestano, F | 1 |
Habib, FK; Stitch, SR | 1 |
Attramadal, A; Djöseland, O; Hansson, V; Naess, O; Torgersen, O; Tveter, KJ; Weddington, SC | 1 |
Horst, HJ; Krieg, M; Voigt, KD | 1 |
Habib, FK; Lee, IR; Smith, PH; Stitch, SR | 1 |
De Sy, W; Vermeulen, A | 1 |
Attramadal, A; Djoseland, O; Hansson, V; Naess, O; Weddington, SC | 1 |
Bard, DR; Lasnitzki, I | 1 |
Barowsky, NJ; Ofner, P; Singer, RM; Tashjian, AH; Vena, RL | 1 |
Hammond, GL | 1 |
Hammond, GL; Kontturi, M; Vihko, P; Vihko, R | 1 |
Cook, B; Cowan, RA; Cowan, SK; Grant, JK; Sirett, DA; Wallace, AM | 1 |
Schweikert, HU | 1 |
Imperato-McGinley, J; Orlic, S; Shackleton, C; Stoner, E | 1 |
Hudson, RW; Wherrett, D | 1 |
Celotti, F; Lechuga, MJ; Martini, L; Melcangi, RC; Motta, M; Negri-Cesi, P; Poletti, A; Zoppi, S | 1 |
Henderson, D | 2 |
Davies, JH; Dowsett, M; Rowlands, MG; Shearer, RJ | 1 |
el Etreby, MF; Habenicht, UF; Neumann, F; Schwarz, K; Schweikert, HU | 1 |
Cocconi, M; Costantini, A; Martini, L; Motta, M; Natali, A; Serio, M; Zoppi, S | 1 |
Fair, WR; Fishman, J; Stone, NN | 1 |
el Etreby, MF; Habenicht, UF; Henderson, D; Kerb, U; Nishino, Y | 1 |
Greco, JP; Kaburagi, Y; Karr, JP; Kirdani, RY; Marino, MB; Sandberg, AA | 1 |
el Etreby, MF; Habenicht, UF; Neumann, F; Schwarz, K | 1 |
Bartsch, W; Klein, H; Stürenburg, HJ; Voigt, KD | 1 |
Ogunlewe, JO; Osegbe, DN | 1 |
Cocconi, M; Martini, L; Motta, M; Serio, M; Zoppi, S | 1 |
Brodie, AM; Inkster, SE; King, DA; Meyer, KM; Son, C | 1 |
el Etreby, MF; Ghoniem, G; Habenicht, UF; Lewis, R; Roberts, J | 1 |
Bongini, M; Bozzolan, F; Doukani, A; Mauvais-Jarvis, P; Poizat, R; Wright, F | 1 |
Albert, J; Geller, J; Kirshner, M; Liu, J | 1 |
Giorgi, EP; Grant, JK; Shirley, IM; Stewart, JC | 1 |
Davies, P; Griffiths, K | 1 |
Griffiths, K; Harper, ME; Peeling, WB; Pike, A | 1 |
Belis, JA; Dieringer, CS; Dombrosky, JT; Lloyd, JW; Mawhinney, MG; Schwartz, FL; Thomas, JA | 1 |
Lloyd, JW; Mawhinney, MG; Schwartz, FL; Thomas, JA | 1 |
Hollmann, HJ; Krieg, M; Steins, P; Voigt, KD | 1 |
Altwein, JE; Klose, K; Knapstein, P; Orestano, F; Rubin, A | 1 |
Butler, AV; McMahon, MJ; Thomas, GH | 1 |
8 review(s) available for androstenedione and Adenoma, Prostatic
Article | Year |
---|---|
The function and the role of aromatase inhibitors in the treatment of BPH.
Topics: Androgens; Androstenedione; Animals; Aromatase Inhibitors; Clinical Trials as Topic; Disease Models, Animal; Estrogens; Flutamide; Humans; Macaca fascicularis; Male; Prostate; Prostatic Hyperplasia | 1994 |
Endocrine therapies for BPH: scientific rationale, clinical results, and patient selection.
Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Androgens; Androstenedione; Animals; Aromatase Inhibitors; Clinical Trials as Topic; Gonadotropin-Releasing Hormone; Hormones; Humans; Male; Models, Biological; Patient Selection; Prostate; Prostatic Hyperplasia | 1994 |
Management of benign prostatic hyperplasia with particular emphasis on aromatase inhibitors.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Estradiol; Humans; Male; Prostatic Hyperplasia; Tamoxifen | 1993 |
Atamestane: an aromatase inhibitor for the treatment of benign prostatic hyperplasia. A short review.
Topics: Androgens; Androstenedione; Animals; Aromatase Inhibitors; Dogs; Estrogens; Female; Humans; Male; Ovary; Prostatic Hyperplasia; Receptors, Androgen; Receptors, Estrogen | 1993 |
Androgen binding and metabolism in the human prostate.
Topics: Androgens; Androstanes; Androstenedione; Animals; Cytosol; Dihydrotestosterone; Humans; Male; Muscles; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Protein Binding; Rats; Receptors, Cell Surface; Testosterone | 1975 |
Androgen metabolism in patients with benign prostatic hypertrophy.
Topics: Adult; Aged; Aging; Androgens; Androstane-3,17-diol; Androstanes; Androstenedione; Androsterone; Animals; Blood Proteins; Cyproterone; Dihydrotestosterone; Estradiol; Estrogens; Female; Humans; Male; Middle Aged; Muscles; Progestins; Prostate; Prostatic Hyperplasia; Protein Binding; Testosterone | 1975 |
Androgen metabolism in different target tissues.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Aging; Androstenedione; Animals; Brain; Cricetinae; Dihydrotestosterone; Humans; Male; Pituitary Gland; Prostate; Prostatic Hyperplasia; Rats; Testosterone | 1990 |
Aromatase inhibitors: their biochemistry and clinical potential.
Topics: 17-Hydroxysteroid Dehydrogenases; 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androstenedione; Animals; Aromatase Inhibitors; Breast Neoplasms; Chemical Phenomena; Chemistry; Estrogens; Female; Humans; Male; Oxidoreductases; Prostatic Hyperplasia | 1987 |
9 trial(s) available for androstenedione and Adenoma, Prostatic
Article | Year |
---|---|
A prospective study of plasma hormone levels, nonhormonal factors, and development of benign prostatic hyperplasia.
Topics: Adult; Aged; Alcohol Drinking; Androstenedione; Blood Pressure; Case-Control Studies; Dihydrotestosterone; Estradiol; Estrone; Exercise; Humans; Male; Middle Aged; Odds Ratio; Prospective Studies; Prostatic Hyperplasia; Testosterone | 1995 |
Effects on the endocrine system of long-term treatment with the non-steroidal anti-androgen Casodex in patients with benign prostatic hyperplasia.
Topics: Aged; Androgen Antagonists; Androstenedione; Anilides; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Double-Blind Method; Estradiol; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Nitriles; Prolactin; Prostatic Hyperplasia; Testosterone; Tosyl Compounds | 1995 |
Placebo controlled double-blind study to test the efficacy of the aromatase inhibitor atamestane in patients with benign prostatic hyperplasia not requiring operation. The Schering 90.062 Study Group.
Topics: Aged; Androstenedione; Aromatase Inhibitors; Double-Blind Method; Humans; Male; Prospective Studies; Prostatic Hyperplasia | 1995 |
Endocrine therapy for benign prostatic hyperplasia in the 90's.
Topics: Androstenedione; Aromatase Inhibitors; Controlled Clinical Trials as Topic; Double-Blind Method; Enzyme Inhibitors; Finasteride; Humans; Male; Placebos; Prostatic Hyperplasia; Testolactone | 1995 |
Effects on the endocrine system of long-term treatment with the luteinizing hormone-releasing hormone agonist leuprolide in patients with benign prostatic hyperplasia.
Topics: Aged; Androstenedione; Dehydroepiandrosterone Sulfate; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Luteinizing Hormone; Male; Placebos; Prostatic Hyperplasia | 1996 |
Estrogen reduction by aromatase inhibition for benign prostatic hyperplasia: results of a double-blind, placebo-controlled, randomized clinical trial using two doses of the aromatase-inhibitor atamestane. Atamestane Study Group.
Topics: Aged; Androgens; Androstenedione; Aromatase Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Estrone; Humans; Male; Middle Aged; Placebos; Prostatic Hyperplasia | 1996 |
The concentrations of the endogenous C19-steroids in hyperplastic prostatic tissue and the effect of finasteride treatment.
Topics: 5-alpha Reductase Inhibitors; Aged; Androstenedione; Dihydrotestosterone; Enzyme Inhibitors; Epitestosterone; Finasteride; Humans; Male; Middle Aged; Prostatic Hyperplasia; Steroids; Testosterone | 1996 |
Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Aged; Aged, 80 and over; Androgens; Androstenedione; Dihydrotestosterone; Double-Blind Method; Finasteride; Humans; Male; Middle Aged; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Testosterone | 1997 |
C19 and C21 5 beta/5 alpha metabolite ratios in subjects treated with the 5 alpha-reductase inhibitor finasteride: comparison of male pseudohermaphrodites with inherited 5 alpha-reductase deficiency.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Aged; Androstenedione; Androstenes; Androsterone; Azasteroids; Corticosterone; Dihydrotestosterone; Disorders of Sex Development; Etiocholanolone; Finasteride; Gas Chromatography-Mass Spectrometry; Humans; Hydrocortisone; Liver; Luteinizing Hormone; Male; Middle Aged; Prostatic Hyperplasia; Radioimmunoassay; Randomized Controlled Trials as Topic; Steroids, Heterocyclic; Testosterone | 1990 |
59 other study(ies) available for androstenedione and Adenoma, Prostatic
Article | Year |
---|---|
Simultaneous quantification of oestrogens and androgens in the serum of patients with benign prostatic hyperplasia by liquid chromatography-Tandem mass spectrometry.
Topics: Aged; Androgens; Androstenedione; Chromatography, Liquid; Dihydrotestosterone; Estrogens; Humans; Male; Prostatic Hyperplasia; Tandem Mass Spectrometry; Testosterone | 2020 |
The role of sex steroid hormones in benign prostatic hyperplasia.
Topics: Age Distribution; Aged; Aged, 80 and over; Androgens; Androstenedione; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Estrogens; Humans; Linear Models; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Statistics, Nonparametric; Testosterone | 2017 |
Growth factor expression in early stages of benign prostatic hyperplasia upon exposure to sustained delivery of androgens.
Topics: Androgens; Androstenedione; Animals; Calcium Phosphates; Dihydrotestosterone; Drug Implants; Endothelium, Vascular; Epidermal Growth Factor; Fibroblast Growth Factors; Male; Prostate; Prostatic Hyperplasia; Rats; Reference Values; Testosterone | 2003 |
Evaluation of androgen metabolism studies in human prostate cancer--correlation with zinc levels.
Topics: Aged; Androgens; Androstenedione; Carcinoma; Dihydrotestosterone; Humans; Male; Middle Aged; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone; Zinc | 1980 |
Altered androgen metabolism in carcinoma of the prostate.
Topics: Androstenediols; Androstenedione; Culture Techniques; Dihydrotestosterone; Male; Oxidation-Reduction; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone | 1981 |
Studies of the nuclear 5 alpha-reductase of human hyperplastic prostatic tissue.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androstenedione; Biotransformation; Cell Nucleus; Cyproterone; Dihydrotestosterone; Humans; Hydrogen-Ion Concentration; Kinetics; Male; Oxidoreductases; Prostatic Hyperplasia; Proteins | 1981 |
Androgens and prostate-specific acid phosphatase in whole tissue and in separated epithelium from human benign prostatic hypertrophic glands.
Topics: Acid Phosphatase; Androgens; Androstane-3,17-diol; Androstenedione; Androsterone; Dihydrotestosterone; Epithelium; Humans; Male; Prostate; Prostatic Hyperplasia; Radioimmunoassay; Testosterone | 1981 |
Relations between circulating levels of testosterone, 17 beta-estradiol, androstenedione, dehydroepiandrosterone sulfate, and androgenic receptor content of cytosol in benign prostatic hyperplasia.
Topics: Aged; Androgens; Androstenedione; Cytosol; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Receptors, Androgen; Receptors, Steroid; Testosterone | 1983 |
The metabolism of androstenedione and testosterone to C19 metabolites in normal breast, breast carcinoma and benign prostatic hypertrophy tissue.
Topics: Androstenedione; Androsterone; Breast; Breast Neoplasms; Dihydrotestosterone; Etiocholanolone; Female; Humans; Male; Prostatic Hyperplasia; Testosterone | 1983 |
[Adrenal androgens and circulating 17 beta-estradiol/testosterone ratio in benign hyperplasia of the prostate].
Topics: Aged; Androstenedione; Dehydroepiandrosterone; Estradiol; Humans; Male; Middle Aged; Prostatic Hyperplasia; Testosterone | 1984 |
Characteristics of the inhibitory effect of chronic treatment with an LHRH agonist on testicular steroidogenesis in the dog.
Topics: 17-alpha-Hydroxyprogesterone; Androgens; Androstenedione; Animals; Buserelin; Castration; Dihydrotestosterone; Dogs; Estrogens; Hydroxyprogesterones; Male; Progesterone; Prostatic Hyperplasia; Testis; Testosterone | 1984 |
[Aromatase inhibitors in the medical treatment of benign prostatic hypertrophy].
Topics: Androstenedione; Aromatase Inhibitors; Humans; Male; Prostatic Hyperplasia | 1993 |
Medical therapy for benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Androstenedione; Aromatase Inhibitors; Finasteride; Gonadotropin-Releasing Hormone; Humans; Male; Prostatic Hyperplasia | 1995 |
Basis for hormonal management of advanced prostate cancer.
Topics: Androstenedione; Animals; Dehydroepiandrosterone; Dihydrotestosterone; Humans; Male; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Orchiectomy; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Protein Biosynthesis; Rats; Testosterone | 1993 |
Effects of estrogen deprivation on human benign prostatic hyperplasia.
Topics: Aged; Aged, 80 and over; Androstenedione; Aromatase Inhibitors; Estradiol; Estrone; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia | 1993 |
Effects of oral administration of chlormadinone acetate on canine prostatic hypertrophy.
Topics: Administration, Oral; Androstenedione; Animals; Chlormadinone Acetate; Dihydrotestosterone; Dog Diseases; Dogs; Estradiol; Luteinizing Hormone; Male; Prostate; Prostatic Hyperplasia; Reference Values | 1993 |
Effect of aromatase inhibitor, TZA-2209, on the prostate of androstenedione-treated castrated dogs: changes in prostate volume and histopathological findings.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Carrier Proteins; Castration; Dogs; Estramustine; Immunoenzyme Techniques; Male; Organ Size; Prostate; Prostatic Hyperplasia; Prostatic Secretory Proteins; Stromal Cells; Testolactone | 1996 |
Concentration of the endogenous antiandrogen epitestosterone and androgenic C19-steroids in hyperplastic prostatic tissue.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Androstenedione; Chromatography, High Pressure Liquid; Dihydrotestosterone; Epitestosterone; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Radioimmunoassay; Testosterone | 1996 |
Testosterone metabolism in primary cultures of epithelial cells and stroma from benign prostatic hyperplasia.
Topics: 17-Hydroxysteroid Dehydrogenases; Androstenedione; Aromatase; Cells, Cultured; Cholestenone 5 alpha-Reductase; Cytosol; Epithelium; Fibroblasts; Humans; Male; Oxidation-Reduction; Oxidoreductases; Prostatic Hyperplasia; Testosterone | 1996 |
Epitestosterone in human blood and prostatic tissue.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Androstenedione; Child; Dihydrotestosterone; Epitestosterone; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Reference Values; Testosterone | 1997 |
5alpha-reductase isozymes and aromatase are differentially expressed and active in the androgen-independent human prostate cancer cell lines DU145 and PC3.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Anastrozole; Androgens; Androstenedione; Aromatase; Aromatase Inhibitors; Blotting, Southern; Dihydrotestosterone; Enzyme Inhibitors; Etiocholanolone; Humans; Hydrogen-Ion Concentration; Isoenzymes; Male; Microsomes; Nitriles; Prostatic Hyperplasia; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Testosterone; Triazoles; Tumor Cells, Cultured | 1999 |
Stable expression of human 5alpha-reductase type II in COS1 cells due to chromosomal gene integration: a novel tool for inhibitor identification.
Topics: Androstenedione; Animals; Base Sequence; Cholestenone 5 alpha-Reductase; Chromosome Mapping; COS Cells; Dihydrotestosterone; DNA Primers; Drug Evaluation, Preclinical; Enzyme Inhibitors; Gene Expression; Humans; Isoenzymes; Male; Oxidoreductases; Plasmids; Prostatic Hyperplasia; Recombinant Proteins; Transfection | 2001 |
A systematic study of testosterone metabolism in benign prostatic hypertrophy (BPH): in vitro results.
Topics: Androstane-3,17-diol; Androstanes; Androstenedione; Culture Techniques; Dihydrotestosterone; Freezing; Heparin; Histocytochemistry; Humans; Hydrogen-Ion Concentration; Kinetics; Male; Prostatic Hyperplasia; Testosterone; Time Factors; Tritium | 1975 |
Letter: Hormones, elderly testes, and carcinoma of the prostate.
Topics: Androgens; Androstenedione; Dihydrotestosterone; Humans; Male; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone | 1975 |
Androgen levels in the plasma and prostatic tissues of patients with benign hypertrophy and carcinoma of the prostate.
Topics: Aged; Androgens; Androstenedione; Dihydrotestosterone; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone | 1976 |
Androgens in patients with benign prostatic hyperplasia before and after prostatectomy.
Topics: Aged; Androgens; Androstenedione; Dehydroepiandrosterone; Dihydrotestosterone; Estradiol; Humans; Hydroxyprogesterones; Male; Middle Aged; Prostatectomy; Prostatic Hyperplasia; Testosterone | 1976 |
Androgen receptors in male sex tissues of rats and humans.
Topics: Androstane-3,17-diol; Androstenedione; Animals; Dihydrotestosterone; Epididymis; Humans; Male; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Rats; Receptors, Androgen; Receptors, Steroid; Testis; Testosterone | 1976 |
The influence of oestradiol on the metabolism of androgens by human prostatic tissue.
Topics: Aged; Androgens; Androstenedione; Dihydrotestosterone; Estradiol; Humans; Male; Middle Aged; Organ Culture Techniques; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone | 1977 |
Comparative C19-radiosteroid metabolism by MA 160 and HeLa cell lines.
Topics: Androstane-3,17-diol; Androstanes; Androstenediols; Androstenedione; Androsterone; Carbon Radioisotopes; Cell Line; Dihydrotestosterone; Epithelial Cells; Epithelium; Fibroblasts; HeLa Cells; Humans; Male; Prostatic Hyperplasia; Skin; Testosterone; Tritium | 1977 |
Endogenous steroid levels in the human prostate from birth to old age: a comparison of normal and diseased tissues.
Topics: Adolescent; Adult; Aged; Aging; Androgens; Androstanes; Androstenedione; Androsterone; Humans; Hydroxyprogesterones; Infant, Newborn; Male; Middle Aged; Progesterone; Prostate; Prostatic Hyperplasia; Testosterone | 1978 |
Serum steroids in normal males and patients with prostatic diseases.
Topics: Adult; Aged; Aging; Androstenedione; Androsterone; Dihydrotestosterone; Estradiol; Humans; Hydroxyprogesterones; Male; Middle Aged; Pregnenolone; Progesterone; Prostatic Hyperplasia; Prostatic Neoplasms; Reference Values; Steroids; Testosterone | 1978 |
Testosterone 5 alpha-reductase and the accumulation of dihydrotestosterone in benign prostatic hyperplasia.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androstenedione; Dihydrotestosterone; Humans; Male; Oxidoreductases; Prostate; Prostatic Hyperplasia; Testosterone | 1979 |
Conversion of androstenedione to estrone in human fibroblasts cultured from prostate, genital and nongenital skin.
Topics: Adolescent; Adult; Aged; Androstenedione; Cells, Cultured; Estrone; Fibroblasts; Humans; Kinetics; Male; Middle Aged; Penis; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Skin | 1979 |
Comparison of the nuclear 5 alpha-reduction of testosterone and androstenedione in human prostatic carcinoma and benign prostatic hyperplasia.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androstenedione; Cell Fractionation; Cell Nucleus; Humans; Kinetics; Male; NADP; Oxidation-Reduction; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone | 1990 |
Estrogens and benign prostatic hyperplasia: rationale for therapy with aromatase inhibitors.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Estrogens; Humans; Male; Prostatic Hyperplasia | 1991 |
Comparison of aromatase activity in human prostatic, testicular and placental tissues.
Topics: Androstenedione; Animals; Aromatase; Aromatase Inhibitors; Carcinoma; Female; Humans; Male; Microsomes; Placenta; Pregnancy; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Rats; Testis; Tissue Distribution | 1991 |
Development of a model for the induction of estrogen-related prostatic hyperplasia in the dog and its response to the aromatase inhibitor 4-hydroxy-4-androstene-3,17-dione: preliminary results.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Castration; Dogs; Estradiol; Male; Prostate; Prostatic Hyperplasia; Time Factors | 1986 |
In vitro effects of an aromatase inhibitor on 5 alpha-reductase activity in human hypertrophic prostatic tissue.
Topics: 5-alpha Reductase Inhibitors; Aged; Androstane-3,17-diol; Androstenedione; Aromatase Inhibitors; Azasteroids; Dihydrotestosterone; Humans; In Vitro Techniques; Male; Middle Aged; Prostatic Hyperplasia; Testosterone | 1986 |
Estrogen formation in human prostatic tissue from patients with and without benign prostatic hyperplasia.
Topics: Adult; Aged; Androstenedione; Aromatase Inhibitors; Estradiol; Estrogens; Estrone; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia | 1986 |
Aromatase inhibitors and benign prostatic hyperplasia.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Gonadotropins, Equine; Humans; Kinetics; Male; Prostatic Hyperplasia; Species Specificity | 1986 |
The possibility of aromatization of androgen in human prostate.
Topics: Androstenedione; Aromatase; Estradiol; Estrone; Humans; Male; Prostate; Prostatic Hyperplasia; Tritium | 1987 |
Synergic inhibitory effects of the aromatase inhibitor 1-methyl-androsta-1, 4-diene-3, 17-dione and the antiandrogen cyproterone acetate on androstenedione-induced hyperplastic effects in the prostates of castrated dogs.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Castration; Cyproterone; Cyproterone Acetate; Dogs; Drug Synergism; Drug Therapy, Combination; Male; Prostate; Prostatic Hyperplasia; Time Factors | 1987 |
Induction of estrogen-related hyperplastic changes in the prostate of the cynomolgus monkey (Macaca fascicularis) by androstenedione and its antagonization by the aromatase inhibitor 1-methyl-androsta-1,4-diene-3,17-dione.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Disease Models, Animal; Estradiol; Macaca fascicularis; Male; Organ Size; Prostate; Prostatic Hyperplasia | 1987 |
Metabolism of androgens in human benign prostatic hyperplasia: aromatase and its inhibition.
Topics: 17-Hydroxysteroid Dehydrogenases; Androgens; Androstenedione; Aromatase; Aromatase Inhibitors; Estrone; Humans; Male; Microsomes; Placenta; Prostate; Prostatic Hyperplasia; Testolactone | 1987 |
Androgen concentration in blacks with benign and malignant prostatic disease.
Topics: Aged; Androgens; Androstenediols; Androstenedione; Black People; Dihydrotestosterone; Humans; Male; Middle Aged; Nigeria; Prostate; Prostatic Hyperplasia; Radioimmunoassay; Testosterone | 1988 |
New approaches for the treatment of prostatic hypertrophy and cancer.
Topics: Aged; Androgens; Androstenedione; Animals; Carbon Radioisotopes; Humans; Kinetics; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Rats; Rats, Inbred Strains | 1987 |
Selective inhibition of androstenedione-induced prostate growth in intact beagle dogs by a combined treatment with the antiandrogen cyproterone acetate and the aromatase inhibitor 1-methyl-androsta-1,4-diene-3,17-dione (1-methyl-ADD).
Topics: Androgen Antagonists; Androstenedione; Animals; Aromatase Inhibitors; Cyproterone; Cyproterone Acetate; Dogs; Epididymis; Luteinizing Hormone; Male; Organ Size; Prostate; Prostatic Hyperplasia; Radioimmunoassay; Testis | 1989 |
Lack of evidence for aromatase in human prostatic tissues: effects of 4-hydroxyandrostenedione and other inhibitors on androgen metabolism.
Topics: Androstenedione; Aromatase; Cholestenone 5 alpha-Reductase; Estrogens; Humans; In Vitro Techniques; Male; Oxidoreductases; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone | 1989 |
Induction of metachromasia in experimentally induced hyperplastic/hypertrophic changes in the prostate of the cynomolgus monkey (Macaca fascicularis).
Topics: Androstenedione; Animals; Aromatase Inhibitors; Macaca fascicularis; Male; Prostate; Prostatic Hyperplasia; Staining and Labeling | 1989 |
Decreased urinary 5 alpha-androstane-3 alpha,17 beta-diol glucuronide excretion in patients with benign prostatic hyperplasia.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aging; Androstane-3,17-diol; Androstanols; Androstenedione; Dihydrotestosterone; Humans; Male; Middle Aged; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone | 1985 |
Acute effects of testicular and adrenal cortical blockade on protein synthesis and dihydrotestosterone content of human prostate tissue.
Topics: Adrenal Cortex; Aged; Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dexamethasone; Dihydrotestosterone; Epithelium; Humans; Hydrocortisone; Male; Megestrol; Megestrol Acetate; Middle Aged; Prostate; Prostatic Hyperplasia; Protein Biosynthesis; Testis; Testosterone | 1985 |
Androgen dynamics in vitro in the human prostate gland. Effect of cyproterone and cyproterone acetate.
Topics: Acetates; Aged; Androgen Antagonists; Androstenedione; Biological Transport; Carbon Isotopes; Cyproterone; Dihydrotestosterone; Humans; Male; Middle Aged; Pregnadienes; Prostate; Prostatic Hyperplasia; Testosterone; Time Factors; Tritium | 1973 |
Hormonal effects in vitro on ribonucleic acid polymerase in nuclei isolated from human prostatic tissue.
Topics: Androstanes; Androstenedione; Cell Nucleus; Diethylstilbestrol; DNA-Directed RNA Polymerases; Humans; In Vitro Techniques; Male; Mustard Compounds; Prostatic Hyperplasia; Testosterone | 1973 |
Steroids of adrenal origin metabolized by human prostatic tissue both in vivo and in vitro.
Topics: Androstanes; Androstenedione; Androsterone; Dehydroepiandrosterone; Dihydrotestosterone; Epithelium; Humans; In Vitro Techniques; Male; Prostate; Prostatectomy; Prostatic Hyperplasia; Testosterone; Tritium | 1974 |
Cystic dilatation of sex accessory organs in common and inbred Syrian Hamsters.
Topics: 17-Hydroxycorticosteroids; Aging; Androstanes; Androstenedione; Animals; Chromatography, Thin Layer; Dihydrotestosterone; Epithelium; Haplorhini; Inbreeding; Male; Prostatic Hyperplasia; Species Specificity; Sterols; Syria; Testosterone; Tritium | 1974 |
Androgen assimilation by normal and hyperplastic dog prostate glands.
Topics: Androstenedione; Androstenols; Animals; Binding, Competitive; Cell Membrane; Chromatography, Thin Layer; Dihydrotestosterone; Dogs; Estradiol; Histocytochemistry; In Vitro Techniques; Male; NADP; Progesterone; Prostate; Prostatic Hyperplasia; Stimulation, Chemical; Testosterone; Time Factors; Tritium | 1974 |
In vitro studies of testosterone and 5alpha-dihydrotestosterone binding in benign prostatic hypertrophy.
Topics: Aged; Androstenedione; Binding Sites; Blood Proteins; Centrifugation, Density Gradient; Charcoal; Cytosol; Dihydrotestosterone; Electrophoresis; Estradiol; Humans; Immunodiffusion; Immunoglobulin G; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Protein Binding; Serum Albumin; Testosterone; Tritium | 1974 |
Testosterone metabolism in benign prostatic hypertrophy. Suppression by diethylstilbestrol and gestonorone capronate.
Topics: Androstanes; Androstenedione; Diethylstilbestrol; Dihydrotestosterone; Gestonorone Caproate; Humans; In Vitro Techniques; Kinetics; Male; Oxidoreductases; Prostate; Prostatic Hyperplasia; Testosterone; Tritium | 1974 |
Testosterone metabolism in cultured hyperplasia of the human prostate.
Topics: 17-Hydroxycorticosteroids; Androstanes; Androstenedione; Androsterone; Animals; Carbon Radioisotopes; Cattle; Chromatography, Paper; Chromatography, Thin Layer; Dehydroepiandrosterone; Dihydrotestosterone; Horses; Humans; Male; Organ Culture Techniques; Prostate; Prostatic Hyperplasia; Sterols; Testosterone; Time Factors; Tritium | 1974 |